Chargement en cours...
Impact of the Medicare Modernization Act of 2003 on Utilization and Spending for Medicare Part B Covered Biologicals in Rheumatoid Arthritis
OBJECTIVE: To examine changes in utilization and expenditures for infliximab in RA patients associated with the two changes implemented by the Medicare Modernization Act (MMA) of 2003, namely (1) reductions in physician reimbursement for Part B drugs between 2003 and 2005 and (2) availability of alt...
Enregistré dans:
| Auteurs principaux: | , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2010
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3007602/ https://ncbi.nlm.nih.gov/pubmed/20391481 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acr.20010 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|